South Korea: Lunit prepares for KOSDAQ IPO in Q2

Lunit, a Korean Medical AI company, has announced preliminary approval from the Korea Exchange for an IPO on the KOSDAQ market. It plans to submit a registration statement within the second quarter of 2022. Founded in 2013, Lunit’s AI technology focuses on R&D of medical software to assist tumor diagnosis and treatment. It processes medical…

You must be a HMI Subscriber to view this content.

Subscribe Now »